Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DOV PHARMACEUTICAL INC | 387,000 | reported | 16 May 2008 | tx 8+1,009,333−127,000 |
| AVANIR PHARMACEUTICALS | 336,394 | reported | 12 Feb 2014 | tx 12+336,394 |
| Syndax Pharmaceuticals Inc | 239,763 | reported | 04 Feb 2026 | tx 34+511,178−272,830 |
| HEPALIFE TECHNOLOGIES INC | 85,254 | reported | 03 May 2019 | tx 3+141,529 |
| Regado Biosciences Inc | 0 | reported | 01 Nov 2016 | tx 15+616,340−163,311 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Feb 2026 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 48,000 | 0.00 USD | |
| 18 Aug 2025 | SALE | Syndax Pharmaceuticals Inc | 19,200 | 15.84 USD | |
| 18 Aug 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 19,200 | 7.20 USD | |
| 15 Aug 2025 | SALE | Syndax Pharmaceuticals Inc | 19,200 | 15.54 USD | |
| 15 Aug 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 19,200 | 7.20 USD | |
| 14 Aug 2025 | SALE | Syndax Pharmaceuticals Inc | 19,200 | 14.19 USD | |
| 14 Aug 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 19,200 | 7.20 USD | |
| 18 Aug 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 19,200 | 0.00 USD | deriv |
| 14 Aug 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 19,200 | 0.00 USD | deriv |
| 15 Aug 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 14,400 | 0.00 USD | deriv |
| 15 Aug 2025 | EXERCISE | Syndax Pharmaceuticals Inc | 4,800 | 0.00 USD | deriv |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 50,000 | 0.00 USD | |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 34,000 | 0.00 USD | |
| 02 Feb 2023 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 32,000 | 0.00 USD | |
| 16 Sept 2022 | SALE | Syndax Pharmaceuticals Inc | 5,419 | 23.43 USD | |
| 16 Sept 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 6,556 | 6.35 USD | |
| 16 Sept 2022 | SALE | Syndax Pharmaceuticals Inc | 6,556 | 23.43 USD | |
| 15 Sept 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 66,840 | 6.32 USD | |
| 15 Sept 2022 | SALE | Syndax Pharmaceuticals Inc | 66,840 | 24.20 USD | |
| 16 Sept 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 5,419 | 6.32 USD | |
| 16 Sept 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 6,556 | 0.00 USD | deriv |
| 16 Sept 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 5,419 | 0.00 USD | deriv |
| 15 Sept 2022 | EXERCISE | Syndax Pharmaceuticals Inc | 66,840 | 0.00 USD | deriv |
| 02 Feb 2022 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 32,000 | 0.00 USD | |
| 05 Oct 2021 | OTHER | Syndax Pharmaceuticals Inc | 463 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 22 Apr 2021.